Literature DB >> 33670590

Protective Effects of Voluntary Exercise on Hepatic Fat Accumulation Induced by Dietary Restriction in Zucker Fatty Rats.

Yuka Kurosaka1,2,3, Shuichi Machida4, Yoko Shiroya2,3, Hideki Yamauchi3, Kumiko Minato2.   

Abstract

Weight control based on dietary restriction (DR) alone can cause lipid metabolic failure and progression to fatty liver. This study aimed to investigate the effect of exercise on preventing DR-induced hepatic fat accumulation in Zucker fatty (ZF) rats by focusing on the relationship between adipose tissue lipolysis and hepatic fat uptake. Six-week-old male ZF rats were randomly assigned to obese, DR, or DR with exercise (DR + Ex) groups. The DR and DR + Ex groups were fed a restricted diet, with the latter also undergoing voluntary exercise. After 6 weeks, hepatic fat accumulation was observed in the DR group, whereas intrahepatic fat was markedly reduced in the DR + Ex group. Compared with the obese (Ob) group, the DR group exhibited 2.09-fold expression of hepatic fatty acid translocase (FAT)/CD36 proteins (p < 0.01) and 0.14-fold expression of hepatic fatty acid-binding protein (FABP)1 (p < 0.01). There were no significant differences between the DR + Ex group and the Ob group. FAT/CD36 and hepatic triglyceride (TG) expression levels were strongly positively correlated (r = 0.81, p < 0.001), whereas there was a strong negative correlation between FABP1 and hepatic TG expression levels (r = -0.65, p < 0.001). Our results suggest that hepatic fat accumulation induced by DR in ZF rats might be prevented through exercise-induced modifications in FAT/CD36 and FABP1 expression.

Entities:  

Keywords:  CD36; FABP1; diet restriction; exercise; fatty liver; hepatocyte ultrastructure; obesity

Mesh:

Substances:

Year:  2021        PMID: 33670590      PMCID: PMC7922922          DOI: 10.3390/ijms22042014

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  39 in total

1.  Regulation of lipolysis in small and large fat cells of the same subject.

Authors:  Jurga Laurencikiene; Thomas Skurk; Agné Kulyté; Per Hedén; Gaby Aström; Eva Sjölin; Mikael Rydén; Hans Hauner; Peter Arner
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

2.  Body weight-dependent troponin T alternative splicing is evolutionarily conserved from insects to mammals and is partially impaired in skeletal muscle of obese rats.

Authors:  Rudolf J Schilder; Scot R Kimball; James H Marden; Leonard S Jefferson
Journal:  J Exp Biol       Date:  2011-05-01       Impact factor: 3.312

3.  The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.

Authors:  Carla Guzmán; Marta Benet; Sandra Pisonero-Vaquero; Marta Moya; M Victoria García-Mediavilla; M Luz Martínez-Chantar; Javier González-Gallego; José Vicente Castell; Sonia Sánchez-Campos; Ramiro Jover
Journal:  Biochim Biophys Acta       Date:  2013-01-12

Review 4.  Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

Authors:  Michael W Bradbury
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02       Impact factor: 4.052

5.  Characterization of fat metabolism in the fatty liver caused by a high-fat, low-carbohydrate diet: A study under equal energy conditions.

Authors:  Yuka Kurosaka; Yoko Shiroya; Hideki Yamauchi; Hiromi Kitamura; Kumiko Minato
Journal:  Biochem Biophys Res Commun       Date:  2017-04-04       Impact factor: 3.575

6.  Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).

Authors:  Yong-Ho Lee; Kyu Sik Jung; Seung Up Kim; Hye-Jin Yoon; Yu Jung Yun; Byung-Wan Lee; Eun Seok Kang; Kwang-Hyub Han; Hyun Chul Lee; Bong-Soo Cha
Journal:  J Hepatol       Date:  2015-03-12       Impact factor: 25.083

Review 7.  Liver lipid metabolism.

Authors:  P Nguyen; V Leray; M Diez; S Serisier; J Le Bloc'h; B Siliart; H Dumon
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2008-06       Impact factor: 2.130

8.  Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.

Authors:  May-Yun Wang; Paul Grayburn; Shuyuan Chen; Mariella Ravazzola; Lelio Orci; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

9.  Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.

Authors:  Juan M Decara; Francisco Javier Pavón; Juan Suárez; Miguel Romero-Cuevas; Elena Baixeras; Mariam Vázquez; Patricia Rivera; Ana L Gavito; Bruno Almeida; Jesús Joglar; Rafael de la Torre; Fernando Rodríguez de Fonseca; Antonia Serrano
Journal:  Dis Model Mech       Date:  2015-10-01       Impact factor: 5.758

Review 10.  Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

Authors:  Un Ju Jung; Myung-Sook Choi
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.